pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07380230: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

    Sponsor: LI FENG. Phase: NA. Conditions: Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07321730: Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Ovarian Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06806228: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

    Sponsor: Petrov, Andrey. Phase: PHASE1. Conditions: Glioblastoma Multiforme, Diffuse Midline Glioma, H3 K27M-Mutant, Gliosarcoma, Giant Cell Glioblastoma, GBM

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04699630: A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

    Sponsor: SCRI Development Innovations, LLC. Phase: PHASE2. Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07493928: HPV After chemoRadioTherapy

    Sponsor: General University Hospital, Prague. Phase: . Conditions: Cervical Cancer Recurrent, Radiotherapy, Cell Free DNA, HPV

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00898365: Study of Kidney Tumors in Younger Patients

    Sponsor: Children's Oncology Group. Phase: . Conditions: Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00156767: Adrenal Function in Critical Illness

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Adrenal Insufficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07393867: Androgen-responsive POSLUMA-guided Intra-prostatic Boost

    Sponsor: Martin T. King, MD, PhD. Phase: PHASE2. Conditions: Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07499765: Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis

    Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Acute Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03635567: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Cervical Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05464667: Preoperative Irradiation for Stage I Breast Cancer

    Sponsor: Parul Barry. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07646600: Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults

    Sponsor: AstraZeneca. Phase: . Conditions: Dilated Cardiomyopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01587300: Neuroblastoma Biology Study

    Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06004882: Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07543224: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

    Sponsor: Reistone Biopharma Company Limited. Phase: PHASE3. Conditions: Plaque Psoriasis Subjects

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Zika, Influenza

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01296724: PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn Children

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Intensive Care Unit Syndrome

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04363580: Creation of Auditory Processing Disorder Screening Tool in French

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Auditory Processing Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04232280: Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

    Sponsor: ModernaTX, Inc.. Phase: PHASE2. Conditions: Cytomegalovirus Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07227896: Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

    Sponsor: AbbVie. Phase: . Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07672496: Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

    Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Complicated Intra-abdominal Infection (cIAI), Systemic Inflammatory Response, Sepsis, Immune Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07007546: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

    Sponsor: Abbisko Therapeutics Co, Ltd. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997588: EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: PIK3CA-related Overgrowth Spectrum (PROS)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07197788: Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

    Sponsor: Endogenex, Inc.. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07496203: The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections

    Sponsor: Hacettepe University. Phase: NA. Conditions: Osteo Arthritis of the Knee, Pain, Pain Management, Exercise

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598942: Gingival TrxR1 Expression in Periodontal Health and Periodontitis

    Sponsor: Ataturk University. Phase: . Conditions: Periodontitis, Oxidative Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04631042: Developing Brain, Impulsivity and Compulsivity

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Typical Development, Obsessive Compulsive Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06284642: Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

    Sponsor: Second Affiliated Hospital of Nanchang University. Phase: PHASE4. Conditions: Aneurysmal Subarachnoid Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05711186: Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Aortic Valve Stenosis, Symptomatic Aortic Stenosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07104383: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

    Sponsor: Viking Therapeutics, Inc.. Phase: PHASE3. Conditions: Weight Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06486441: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

    Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06156254: Community Care Intervention to Decrease COVID-19 Vaccination Inequities

    Sponsor: RAND. Phase: NA. Conditions: COVID-19 Vaccination

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06658405: Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions

    Sponsor: Centre Oscar Lambret. Phase: PHASE2. Conditions: Cervical Lesion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07597694: Verbal Intent and Gaze Cues on Action Prediction in ASD

    Sponsor: University of Electronic Science and Technology of China. Phase: . Conditions: Autism Spectrum Disorder (ASD), Intellectual Disability

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06747156: A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

    Sponsor: Ruijin Hospital. Phase: EARLY_PHASE1. Conditions: Autoimmune Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06739122: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04545151: Verapamil SR in Adults With Type 1 Diabetes

    Sponsor: Medical University of Graz. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02192151: Study of PHN131 in Healthy Volunteers

    Sponsor: PhytoHealth Corporation. Phase: . Conditions: Analgesia Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06464029: Pathways Mediating Impaired Postural Control in Parkinson's Disease

    Sponsor: University of Minnesota. Phase: . Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07601529: Comparison of Anterior Sciatic Nerve Block and Adductor Magnus Muscle Plane Block for Anterior Cruciate Ligament Surgery

    Sponsor: Ataturk University. Phase: NA. Conditions: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06743529: Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Ventilator-Associated Pneumonia (VAP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06737731: A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors

    Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Malignant Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451431: Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

    Sponsor: Bangladesh Medical University. Phase: PHASE4. Conditions: Diabetic Peripheral Neuropathic Pain (DPNP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06033131: PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

    Sponsor: Lina Bergman. Phase: PHASE3. Conditions: Preeclampsia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07222202: Evaluation of Flexible Conductive Hearing Aids

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Conductive Hearing Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07280637: Regenarative Treatment of Periocular Wrinkles With PDRN

    Sponsor: University of Taubate. Phase: NA. Conditions: Skin Wrinklings

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07145645: Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children

    Sponsor: University of Calgary. Phase: PHASE3. Conditions: Musculoskeletal Injury, Pediatrics, Sprain and Strain of Ankle, Sprain Knee, Strain Knee

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07220772: A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Monogenic Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07146295: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

    Sponsor: Isabelle Henskens. Phase: NA. Conditions: Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Sentinel Lymph Node Detection, Sentinel Lymph Node, Lymphatic Metastasis, Fluorescence Imaging, Indocyanine Green (ICG), Radioisotopes, Lymph Node Mapping

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07668739: Efficacy of Verciguat in TR and RV Failure

    Sponsor: Daejeon St. Mary's hospital. Phase: PHASE4. Conditions: HFrEF, Tricuspid Regurgitation (TR)

    full page →ctgov ↗
    ← prev
    page 77 of 98
    next →